My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Sugar mills produce about 66 Lakh MT of sugar so far
Dec 30,2016

During the current Sugar Season 2016-17, the sugar mills of the country have commenced the crushing operation smoothly and have produced about 66 Lakh MT of sugar so far. The sugar production is expected to be about 22.5 million MT by the end of the season. With a carryover stock of 7.71 million MT, the total availability of sugar is sufficient to meet the estimated domestic requirement of about 25 mMT. The stock position at the close of the current sugar season (Sept. 2017) is likely to be 5.21 mMT which will be carried forward for the next sugar season 2017-18.

Further, the sugar production in the next sugar season (2017-18) is expected to be good and is likely to start early and therefore there will be no shortage of domestically produced sugar in India. By November 2017, another 2 mMT would be available from early crushing. The government has taken necessary steps to maintain sufficient stocks in the country and keep the sugar prices under control.

Powered by Capital Market - Live News

M P Agro Industries announces resignation of director
Dec 30,2016

M P Agro Industries announced that Independent Directors of the Company Poonam Zha, has resigned from the Board and the Board of Directors, in their meeting held on 30 December 2016, has taken the note of the same.

Powered by Capital Market - Live News

Advanced Micronic Devices announces resignation of directors
Dec 30,2016

Advanced Micronic Devices announced that P.V.Chandrasekar has resigned as a Managing Director of the Company with effective from 28 December 2016 and Dr. Suchitra Misra has resigned as a Non Executive Director, with effect from 14 December 2016.

Powered by Capital Market - Live News

Outcome of EGM of Sanguine Media
Dec 30,2016

Sanguine Media announced that the shareholders of the company at the EGM held on 30 December 2016 approved the following -

Consolidation of equity shares from Re 1 each to Rs 10 each

Alteration of Memorandum of Association.

Powered by Capital Market - Live News

VLS Finance appoints director
Dec 30,2016

VLS Finance announced that the Board of Directors had appointed V. G. Kannan as an Additional Director in the category of Independent Director through resolution passed by circulation on 28 December 2016.

Powered by Capital Market - Live News

Skipper announces resignation of company secretary and compliance officer
Dec 30,2016

Skipper announced Arbind Kumar Jain has resigned from the position of Company Secretary & Compliance Officer of the Company with effect from the close of business hours on 29 December 2016.

The Company is in process of identifying new person for the vacant position and shall intimate the stock exchanges once the position is filled up.

Powered by Capital Market - Live News

Igarashi Motors India gets ratings assigned for bank facilities
Dec 30,2016

Igarashi Motors India has received ratings for bank facilities from CARE Ratings as follows -

Long term bank facilities (Rs 31.86 crore) - CARE A+; Stable
Short term bank facilities (Rs 35 crore) - CARE A1+

Long term / short term bank facilities (Rs 20 crore) - CARE A+; Stable / Care A1+.

Powered by Capital Market - Live News

Lupin gains after USFDA tentative nod for generic drug
Dec 30,2016

The announcement was made during market hours today, 30 December 2016.

Meanwhile, the S&P BSE Sensex was up 255.20 points or 0.97% at 26,621.35.

On the BSE, 32,000 shares were traded on the counter so far as against the average daily volumes of 57,000 shares in the past two weeks. The stock had hit a high of Rs 1,490 and a low of Rs 1,469.95 so far during the day.

The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016 and a 52-week low of Rs 1,294.05 on 29 March 2016.

Lupin announced that it has received tentative approval from the United States Food and Drug Administration to market Pitavastatin tablets, 1 mg, 2 mg, and 4 mg, a generic version of Kowa Companys Livalo tablets. The filing is from Lupins Pithampur (Indore) manufacturing facility.

Lupins Pitavastatin tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.

Livalo tablets had annual US sales of $245.3 million (IMS MAT Sep 2016).

Lupins consolidated net profit rose 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-infective and NSAID space and holds global leadership position in the Anti-TB segment.

Powered by Capital Market - Live News

Bajaj Holdings & Investment to announce Q3 and 9M results
Dec 30,2016

Bajaj Holdings & Investment announced that the Board of Directors of the Company will meet on 31 January 2017 to consider, inter alia, the unaudited financial results for the quarter and nine months ending 31 December 2016 (Q3).

Powered by Capital Market - Live News

Carborundum Universal allots equity shares
Dec 30,2016

Carborundum Universal has allotted 8,000 shares of Re.1/- each arising out of the exercise of stock options, granted to the option grantees of the Company under the Employees Stock Option Scheme 2007 on 30 December 2016.

With this allotment the number of equity shares outstanding is 188,624,590 and the paid-up equity share capital is Rs. 188,624,590/-.

Powered by Capital Market - Live News

Board of Bajaj Auto to consider Q3 and 9M results
Dec 30,2016

Bajaj Auto announced that the Board of Directors of the Company will meet on 31 January 2017, inter alia, to consider the unaudited financial results for the quarter and nine months ending 31 December 2016 (Q3).

Powered by Capital Market - Live News

Direct Tax Dispute Resolution Scheme- 2016 extended up to 31st January 2017
Dec 30,2016

In view of the representations received from various stakeholders and for the convenience of the taxpayers, the last date for availing the Direct Tax Dispute Resolution Scheme, 2016 (the Scheme) has been extended up to 31st January 2017. The scheme was to close on 31st December 2016.

In order to reduce the pending litigation, the Scheme was introduced by the Finance Act, 2016. The Scheme came into force from 1st June, 2016 vide notification S.O. 1902(E) dated 26th May, 2016.

Powered by Capital Market - Live News

Sugar stocks in demand
Dec 30,2016

Rana Sugars (up 13.24%), Upper Ganges Sugar & Industries (up 8.29%), Dwarikesh Sugar Industries (up 7.81%), Shree Renuka Sugar (up 6.34%), Sakthi Sugars (up 6.33%), Oudh Sugar Mills (up 6.15%), Empee Sugars and Chemicals (up 6.08%), KCP Sugar & Industries Corporation (up 4.45%), Dhampur Sugar Mills (up 4.42%), Simbhaoli Sugars (up 4.26%), DCM Shriram Industries (up 4.08%), EID Parry (India) (up 3.14%), Balrampur Chini Mills (up 1.59%), Triveni Engineering & Industries (up 1%) and Bajaj Hindusthan Sugar (up 0.21%), edged higher.

The S&P BSE Sensex was up 296.16 points, or 1.12% at 26,662.31.

According to reports, total debt of sugar companies were around Rs 42000 crore at the end of financial year ended March 2016.

Powered by Capital Market - Live News

Lupin receives tentative approval for Pitavastatin Tablets
Dec 30,2016

Lupin has received tentative approval for its Pitavastatin Tablets, 1mg, 2mg and 4mg from United States Food and Drug Administration (USFDA) to market a generic version of Kowa Companys Livalo Tables 1mg, 2mg and 4mg. The filing is from Lupins Pithampur (Indore) manufacturing facility.

Powered by Capital Market - Live News

Board of A2Z Infra Engineering allots shares on conversion of warrants
Dec 30,2016

A2Z Infra Engineering announced that the Board of Directors of the company at its meeting held on 30 December 2016 has allotted 9,07,788 equity shares of Rs 10 each on conversion of warrants. Consequently, the issued and paid up capital of the company is Rs 131.01 crore comprising of 13,10,12,263 equity shares of Rs 10 each.

Powered by Capital Market - Live News